BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6325430)

  • 1. Platelet-derived growth factor receptors form a high affinity state in membrane preparations. Kinetics and affinity cross-linking studies.
    Williams LT; Tremble PM; Lavin MF; Sunday ME
    J Biol Chem; 1984 Apr; 259(8):5287-94. PubMed ID: 6325430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor binds specifically to receptors on vascular smooth muscle cells and the binding becomes nondissociable.
    Williams LT; Tremble P; Antoniades HN
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):5867-70. PubMed ID: 6310551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the growth conditions on the expression of cell-surface-associated platelet-derived growth factor receptors in mouse fibroblasts.
    Zippel R; Morello L; Toschi L; Alberghina L; Comoglio PM; Sturani E
    Biochim Biophys Acta; 1988 Oct; 971(3):351-7. PubMed ID: 2844295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived growth factor. II. Specific binding to cultured cells.
    Bowen-Pope DF; Ross R
    J Biol Chem; 1982 May; 257(9):5161-71. PubMed ID: 6279659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the receptor for platelet-derived growth factor on human fibroblasts. Demonstration of an intimate relationship with a 185,000-Dalton substrate for the platelet-derived growth factor-stimulated kinase.
    Heldin CH; Ek B; Rönnstrand L
    J Biol Chem; 1983 Aug; 258(16):10054-61. PubMed ID: 6309764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived growth factor: morphologic and biochemical studies of binding, internalization, and degradation.
    Rosenfeld ME; Bowen-Pope DF; Ross R
    J Cell Physiol; 1984 Nov; 121(2):263-74. PubMed ID: 6092390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suramin binds to platelet-derived growth factor and inhibits its biological activity.
    Hosang M
    J Cell Biochem; 1985; 29(3):265-73. PubMed ID: 4077932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of human, bovine and porcine platelet-derived growth factor in a radioreceptor assay with human placental membrane protein.
    Czyrski JA; Gawlikowski W
    FEBS Lett; 1987 Jul; 219(2):331-4. PubMed ID: 3038607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived growth factor. III. Identification of a platelet-derived growth factor receptor by affinity labeling.
    Glenn K; Bowen-Pope DF; Ross R
    J Biol Chem; 1982 May; 257(9):5172-6. PubMed ID: 6279660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of the platelet-derived growth factor receptor by using an anti-phosphotyrosine antibody.
    Daniel TO; Tremble PM; Frackelton AR; Williams LT
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2684-7. PubMed ID: 2581254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a platelet-derived growth factor receptor on Swiss 3T3 cells by affinity crosslinking.
    Hosang M
    J Recept Res; 1988; 8(1-4):455-66. PubMed ID: 2838625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-induced dimerization of the platelet-derived growth factor receptor. Monomer-dimer interconversion occurs independent of receptor phosphorylation.
    Bishayee S; Majumdar S; Khire J; Das M
    J Biol Chem; 1989 Jul; 264(20):11699-705. PubMed ID: 2545680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
    Huang JS; Nishimura J; Huang SS; Deuel TF
    J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between the receptors for platelet-derived growth factor and epidermal growth factor.
    Bowen-Pope DF; Dicorleto PE; Ross R
    J Cell Biol; 1983 Mar; 96(3):679-83. PubMed ID: 6300138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat Leydig cells bind platelet-derived growth factor through specific receptors and produce platelet-derived growth factor-like molecules.
    Gnessi L; Emidi A; Farini D; Scarpa S; Modesti A; Ciampani T; Silvestroni L; Spera G
    Endocrinology; 1992 Apr; 130(4):2219-24. PubMed ID: 1312451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The erythropoietin receptor of rat erythroid progenitor lens. Characterization and affinity cross-linkage.
    Mayeux P; Billat C; Jacquot R
    J Biol Chem; 1987 Oct; 262(29):13985-90. PubMed ID: 2820989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-derived growth factor labeled to colloidal gold for use as a mitogenic receptor probe.
    Handley DA; Witte LD
    Eur J Cell Biol; 1984 Jul; 34(2):281-6. PubMed ID: 6090144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor promoter enhances mitogenesis by PDGF with little effect on PDGF binding.
    Eide BL; Krebs EG; Ross R; Pike LJ; Bowen-Pope DF
    J Cell Physiol; 1986 Feb; 126(2):254-8. PubMed ID: 3003126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-derived growth factor treatment decreases the affinity of the epidermal growth factor receptors of Swiss 3T3 cells.
    Collins MK; Sinnett-Smith JW; Rozengurt E
    J Biol Chem; 1983 Oct; 258(19):11689-93. PubMed ID: 6311820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines.
    Massagué J; Like B
    J Biol Chem; 1985 Mar; 260(5):2636-45. PubMed ID: 2982829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.